CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 33,241 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at an average $2.24 ($11,176)
- 4 Open-market buy President and CEO bought 50,000 shares at $2.24 ($112,050)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 91,463 shares (other)
- 4 Open-market buy Director bought 7,000 shares at $2.45 ($17,130)
- 4 Grant or award Director acquired 14,294 shares (grant or award)
- 4 Grant or award Director acquired 9,291 shares (grant or award)
- 4 Grant or award Director acquired 9,291 shares (grant or award)
- 4 Grant or award Director acquired 9,291 shares (grant or award)
- 4 Open-market buy President and CEO bought 18,000 shares at $2.20 ($39,647)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 2,000 shares at an average $1.68 ($3,355)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 27,613 shares (grant or award)
Page 2 of 17 · 332 filings